Position in ALMS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$10,494,915
New position
Shares Held
476,392
first reported quarter
Ownership
0.374%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $280,717,366 across 29 Biotechnology names. ALMS ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
2,089,906 | $51,746,072 | |
| 2 | TECH |
BIO-TECHNE Corp
|
759,712 | $39,702,549 | |
| 3 | INVA |
Innoviva, Inc.
|
1,061,448 | $24,731,738 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
232,923 | $17,296,861 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
94,017 | $15,890,753 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
1,207,223 | $15,295,515 | |
| 7 | CRMD |
CorMedix Inc.
|
1,887,532 | $12,816,342 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
278,064 | $11,044,702 |
All Filings in ALMS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,494,915 | 476,392 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||